Advanced Search
Reset

Day 3 (2018-07-02)

08:30
09:30
Morning Symposium: New and Emerging Issues in Organ Trafficking and Travel for Transplantation
N-111
305.1 Commercial transplants in the developing world
Elmi Muller, South Africa
305.2 Ethical concerns regarding global kidney exchanges
Alexander M Capron, United States
305.3 When the poor donate but only the rich receive – barriers to equitable allocation of organs in developing countries
Sanjay S. Nagral, India
08:30
09:30
Morning Symposium: Sex and gender research in transplantation- where are we now?
N-112
306.1 Where have we been and where are we going in sex and gender research in transplant? A scoping review
Ruth Sapir-Pichhadze, Canada
306.2 Donor sex related factors influencing transplant outcomes
Amanda J Miller, Canada
306.3 Gender disparities in transplantation
Anette Melk, Germany
08:30
09:30
Morning Symposium: Improving Patient Outcomes
N-113
307.1 Fostering healthy lifestyles
Christiane Kugler, Germany
307.2 Promoting transplant adherence
Paolo De Simone, Italy
307.3 Improving psychosocial outcomes
Anna Forsberg, Sweden
08:30
09:30
Morning Symposium: The Transplanter vs. The Educator Ultimate Debate: Should Transplanters Be Trained As Educators?
N-114
308.1 Introduction by Chair
Marcelo Cantarovich, Canada
308.2 The Transplanter
Jeremy R. Chapman, Australia
308.3 The Educator
Medhat Askar, United States
Open debate discussion
,
08:30
09:30
Morning Symposium: Current Immunosuppression: “Can this old dog be taught new tricks?”
N-115/116
309.1 Re-targeting JAK/STAT signaling in solid organ transplantation?
Helio S. Tedesco Jr, Brazil
309.2 Alemtuzumab and Infliximab join forces: Together we are strong
Petra Reinke, Germany
309.3 Proteasome inhibition before and after transplantation
E. Steve Woodle, United States

Day 4 (2018-07-03)

08:30
09:30
Morning Symposium: Clinical applications in stem cells
N-111
405.1 Bottlenecks to clinical application of IpS
Martin Hoogduijn, Netherlands
405.2 Clinical trials for stem-based regenerative medicine
Toshio Miki, United States
Panel Discussions
,
08:30
09:30
Morning Symposium: The future of thoracic transplantation
N-112
406.1 Assessment of frailty and comorbidities
Cynthia Gries, United States
406.2 Efforts to increase the lung donor pool
Dirk Van Raemdonck, Belgium
406.3 Efforts to increase the heart donor pool
Peter S. MacDonald, Australia
08:30
09:45
Morning Symposium: Issues relating to clinical xenotransplantation
N-113
407.1 Are low anti-pig antibody levels essential to the succcess of pig organ xenotransplantation?
Emanuele E Cozzi, Italy
407.2 Is encapsulated pig islet Tx preferable to free pig islet Tx?
Rita Bottino, United States
407.3 Is pig genetic engineering essential for the success of xenotransplantation?
Kazuhiko Yamada, United States
Presentation of the 2017 Carl-Gustav Groth Xeno Prize
Zurab Machaidze, United States
Heidi Yeh, United States
08:30
09:30
Morning Symposium: Controversies in Intestinal Transplant
N-114
408.1 Should every country have an intestinal transplant program? Yes
Rodrigo Vianna, United States
408.2 Should every country have an intestinal transplant program? No
George V. Mazariegos, United States
Open debate discussion
,
408.3 Cipo: pre-emptive transplant - Yes
Francisco Hernandez, Spain
408.4 CIPO: Pre-emptive transplant - No
Florence Lacaille, France
Open debate discussion
,
08:30
09:30
Morning Symposium: Trends in Paediatric Transplantation
N-115/116
409.1 Paediatric PTLD pearls
Stephen D Marks, United Kingdom
409.2 Donor specific antibodies in paediatrics
Burkhard Tönshoff, Germany
409.3 Ethical issues in paediatric transplantation: an update on current issues
Rebecca Greenberg, Canada
08:30
09:30
Morning Symposium: Opt Out - New Experiences in Presumed Consent
N-117/118
410.1 The Wales experience
Katja Empson, United Kingdom
410.2 The US opt in experience
Susan Gunderson, United States
410.3 Opt in-opt out - the European experience
Bernadette B.J.J.M. Haase-Kromwijk, Netherlands

Day 5 (2018-07-04)

08:30
09:30
Morning Symposium: Organ Donor Management- Impact of Critical care and Outcome
N-111
505.1 Organ donation: Changing perspectives in critical care - donor management goals
Darren Malinoski, United States
505.2 Critical care training and education for donor coordinators
Sharon Swain, United States
505.3 Donation after cardiac death- the role of critical care
Martí Manyalich, Spain
08:30
09:30
Morning Symposium: What is new in the world of transplant registries?
N-112
506.1 National Transplant Registry of India
Vivek Kute, India
506.2 China
Haibo Wang, P.R. China
506.3 Korean Organ Transplant Registry (KOTRY)
Curie Ahn, Korea
08:30
09:30
Morning Symposium: Innovation and Insights in VCA
N-113
507.1 Whole Eye Transplantation - Hope or Hype?
Fatih Zor, United States
507.2 Immunopathology of VCA Rejection - Knowns and Unknowns
Alice Koenig, France
Panel Discussions
,
08:30
09:30
Morning Symposium: A Discussion of Informed Consent with Living and Deceased Donation
N-114
508.1 The discretionary living kidney donor
Gabriel Danovitch, United States
508.2 Marginal deceased donor
John S. Gill, Canada
508.3 High risk donors
Paolo A. Grossi, Italy
Panel discussions
,
08:30
09:30
Morning Symposium: Beta cell replacement of the future
N-115/116
509.1 Will gene editing carry pig islets to the clinic
Marc Guell, United States
509.2 Advanced insulin delivery systems can they cure patients
Thomas Kay, Australia
509.3 Developing delivery approaches for stem cell transplantation
Shane T. Grey, Australia
08:30
09:30
Morning Symposium: Challenging Cases in Transplant Infectious Diseases: Pushing the Boundaries of Donor and Recipient Outcomes
N-117/118
510.1 Polyoma viruses (BK) - Case presenter
Diana Florescu, United States
510.2 Polyoma viruses (BK) - Case discussant
Hans H. Hirsch, Switzerland
510.3 Marginal donor - Case presenter
Hannah Kaminski, France
510.4 Marginal donor - Case discussant
Francisco M Marty, United States
510.5 Nocardia - Case presenter
Edward A Dominguez, United States
510.6 Nocardia - Case discussant
Cameron Wolfe, United States

Day 6 (2018-07-05)

08:30
09:30
Morning Symposium: Recurrent Disease after Transplantation
N-102
600.1 FSGS
Guillaume Canaud, France
600.2 aHUS
Christophe Legendre, France
08:30
09:30
Morning Symposium: When the liver transplant surgeon need help...
N-105
601.1 The role of interventional endoscopist
Magdy El-Serafy, Egypt
601.2 The role of the interventional radiologist
Pierre Goffette, Belgium
601.3 The role of the liver transplant pathologist
Laura Rubbia-Brandt, Switzerland
08:30
09:30
Morning Symposium: Modern Reinterpretation of Classical Concepts in Transplant Immunology
N-106
602.1 Die another day: Apoptosis, necroptosis and immune activation
Andreas Linkermann, Germany
602.2 Tricky ways of allorecognition: Exosomes and antigen
Adrian E Morelli, United States
602.3 Are we getting there? Novel mechanistic aspects of tolerance induction
Julien Zuber, France
08:30
09:30
Morning Symposium: Kidney Paired Exchange. Success stories, ongoing challenges and what we can learn from others
N-111
604.1 Kidney paired exchange in Canada. What works and what challenges remain. a national approach to KPD
Kathryn Tinckam, Canada
604.2 Kidney paired exchange in Saudi Arabia. Success and lessons
Khalid Kam AlMeshari, Saudi Arabia
604.3 The National Kidney Registry approach to paired exchange
J. Michael Cecka, United States
08:30
09:30
Morning Symposium: Pearls of Wisdom – A roadmap to developing a successful career in transplantation
N-113
606.1 Your first real job - making yourself marketable and finding a clinical niche
Barbara Murphy, United States
606.2 The “How to Guide” for the aspiring physician/surgeon-scientist: Funding and publications
Jeremy R. Chapman, Australia
606.3 The “Holy Grail of Work-Life Balance”: Mindfulness, emotional intelligence and well-being
Nancy Ascher, United States
606.4 How to find a research focus – and funding – as a trainee
Jayme E. Locke, United States
Panel discussions
,
08:30
09:30
Morning Symposium: Tackling the Challenges Posed by Donor Intervention Research
N-115/116
607.1 Why is it difficult to conduct trials testing novel interventions in deceased donors?
Claus Niemann, United States
607.2 Guidance delineated in the National Academies of Medicine Donor Intervention Report
Sandy Feng, United States
607.3 Conducting donor intervention trials in my country – an international panel discussion
Claus Niemann, United States
Axel Rahmel, Germany
Christopher J. E. Watson, United Kingdom
Elisabeth Coll, Spain
Helen I. Opdam, Australia


© 2018 TTS2018